XML 123 R82.htm IDEA: XBRL DOCUMENT v3.25.0.1
Goodwill and Other Intangibles - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Intangible Assets Excluding Goodwill [Line Items]          
Other intangibles, net     $ 16,370 $ 18,011  
Intangible asset impairment charges     39 $ 792 $ 1,749
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]       Research and development Research and development
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]         Research and development
Amortization expense for intangible assets     2,400 $ 2,000 $ 2,100
Estimated aggregate amortization expense, 2025     2,400    
Estimated aggregate amortization expense, 2026     2,300    
Estimated aggregate amortization expense, 2027     2,100    
Estimated aggregate amortization expense, 2028     1,800    
Estimated aggregate amortization expense, 2029     1,500    
IPR&D          
Intangible Assets Excluding Goodwill [Line Items]          
IPR&D intangible asset     430 6,816  
Animal Health          
Intangible Assets Excluding Goodwill [Line Items]          
Other intangibles, net     4,300    
gefapixant | IPR&D          
Intangible Assets Excluding Goodwill [Line Items]          
IPR&D impairment charges       779  
Lyfnua          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     21    
nemtabrutinib | IPR&D          
Intangible Assets Excluding Goodwill [Line Items]          
IPR&D intangible asset     418    
IPR&D impairment charges $ 780 $ 807     1,600
Product rights          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     10,922 5,878  
Product rights | Reblozyl          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     2,800    
Product rights | Zerbaxa          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     260    
Product rights | Animal Health          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     1,700    
Product rights | Winrevair          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     5,900    
Trade names          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     1,927 2,105  
Trade names | Animal Health          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     1,900    
Licenses and other          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     3,091 $ 3,212  
Licenses and other | Lynparza          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     1,200    
Licenses and other | Lenvima          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     442    
Licenses and other | Adempas          
Intangible Assets Excluding Goodwill [Line Items]          
Finite-lived intangible assets, net     $ 372    
Licenses and other | derazantinib          
Intangible Assets Excluding Goodwill [Line Items]          
Intangible asset impairment charge related to finite-lived intangible asset         $ 80